Long COVID Patients Feel 'Failed' By Healthcare System
Many individuals living with long COVID six years after the pandemic's onset report feeling abandoned by the healthcare system. A VTDigger report on Vermonters with the condition found that patients struggle with fluctuating symptoms and a system that fails to provide adequate support for invisible illnesses. This highlights a significant unmet need for tools that validate patient experiences and offer practical management support.
- The economic burden of Long COVID is substantial, with one analysis suggesting a global economic toll of around $1 trillion each year. In the U.S. alone, the total economic cost has been estimated at $3.7 trillion, factoring in lost quality of life, reduced earnings, and increased medical expenses. Another study estimated that the condition resulted in over $12 billion in lost labor costs in the U.S. in 2022. - Digital health funding saw a significant rebound in 2025, with U.S. startups raising $14.2 billion, a 35% increase from 2024. This growth was largely driven by larger investments in a smaller number of companies, particularly those leveraging artificial intelligence. AI-enabled healthcare startups captured 62% of venture capital in the first half of 2025 and commanded higher average deal sizes. - Artificial intelligence is being increasingly applied to chronic disease management to provide personalized decision support, continuous monitoring, and risk prediction. AI-powered conversational agents and mobile health platforms are also used to deliver education, support treatment adherence, and provide coaching. Studies show AI can improve medication adherence by over 30%. - The global wellness app market is projected to exceed $26 billion by 2030, with an annual growth rate of nearly 15%. The broader mobile health app market is expected to grow from $62.5 billion in 2026 to $145.3 billion by 2033. This growth is fueled by the increasing use of wearable devices and a greater consumer focus on health. - For consumer health apps, HIPAA compliance is a key consideration, applying to "covered entities" and their "business associates" who handle protected health information (PHI). However, many direct-to-consumer wellness apps that collect information directly from users fall outside of HIPAA's scope, instead being governed by the FTC's Health Breach Notification Rule and various state privacy laws. - Patient advocacy groups like the Long COVID Alliance and Long Covid SOS have been instrumental in pushing for recognition, research, and support for those with post-viral illnesses. These groups, often led by patients themselves, provide a crucial link between patients, researchers, and policymakers. - Research into longevity and "geroscience" is exploring the links between aging processes and post-viral illnesses like Long COVID and ME/CFS. Studies are investigating how processes like chronic inflammation, mitochondrial dysfunction, and cellular senescence—all hallmarks of aging—are present in Long COVID, and whether anti-aging interventions could be beneficial. - The wearable technology market is a significant driver of digital health innovation, projected to grow from $84.2 billion in 2024 to over $186 billion by 2030. Startups are leveraging wearables for continuous, real-time monitoring of physiological data to personalize care for chronic conditions, women's health, and cardiac monitoring.
